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ABSTRACT 
Trigonella foenum graecum commonly known as Fenugreek exerts normoglycemic and insu-
linotropic effects in humans by compounds from its seed and leaf extracts. Some studies re-
ported that treating pregnant mice with fenugreek seed could cause toxic effects on the nerv-
ous system of its pubs during developmental growth, while in some other studies neuroprotec-
tive properties were considered for it. Safety of anti-diabetic drugs for nervous system is very 
important because peripheral neuropathy is a common complication of diabetes and hazard-
ous drugs could worsen it. In this study, the effect of treatment with fenugreek seed extract on 
the function of sciatic nerves of neuropathic mice was evaluated. 
Neuropathy was induced in male mice by pyridoxine intoxication. After that, animals were 
treated with 0.2, 2 and 20 mg/kg of hydro-alcoholic extract of fenugreek seeds for 10 days, 
tail flick, electrophysiological and histological assays were performed to evaluate the effect of 
fenugreek seed extract on function of the peripheral nerves. Our data showed that fenugreek 
has anti neuropathic effect and restores the function of nerve fibers. Results of electrophysio-
logical recordings stated that the highest rate of healing was occurred in 20 mg/kg fenugreek 
extract treated animals.  
In conclusion, findings of the present study demonstrate that treatment with fenugreek seed 
extract can potentially facilitate healing from pyridoxine induced peripheral neuropathy in 
mice. 
 





Peripheral neuropathy is a common 
complication of many disorders, such as 
metabolic, infectious and auto-immune dis-
eases (Gorshtein and Levy, 2005). Because 
of its high incidence in diabetes, it is one of 
the major complications in diabetic patients 
(Gregory et al., 2012). Control of neuropa-
thy in diabetic patients is difficult and even 
with precise control of blood glucose the 
risk of neuropathy prevalence still remains 
(Callaghan et al., 2012). Consequently, 
among candidate drugs and herbals for 
treatment of diabetes, some of them that 
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exert both normoglycemic and neuroprotec-
tive effects could be more appropriate for 
control of disease.  
Fenugreek (Trigonella foenum grae-
cum) is a plant that belongs to the Legumi-
nosae family (Kaviarasan et al., 2006). It is 
established that fenugreek seed extract has 
anti-diabetic effects through several path-
ways, such as restoring pancreatic β cell 
function and inhibiting sucrase and alpha-
amylase activities (Baquer et al., 2011). It is 
full of 4-hydroxyisoleucine, which directly 
induces insulin secretion from pancreatic β 
cells (Kaviarasan et al., 2006). Furthermore, 
there are some evidences that its seed ex-
tract reduces serum triglycerides, total cho-
lesterol (TC) and low-density lipoprotein 
cholesterol (LDL-C) (Baquer et al., 2011). 
Beside these properties, some anti-
inflammatory and anti-nociceptive actions 
were also attributed to its seed extract 
(Kawabata et al., 2011). 
Otherwise there are some reports about 
its hazardous developmental side effects on 
the nervous system of human infants, which 
their mothers used fenugreek seed during 
gestation (Khalki et al., 2012). According to 
animal studies, exposure of pregnant mice 
to high dose (more than 500 mg/kg) of fe-
nugreek seed extract could cause neuro-
developmental defects in pubs (Khalki et 
al., 2012). Another study showed that, feed-
ing diabetic rats with fenugreek seed pow-
der (5 % w/w) mixed with standard pellet 
food reduces their blood glucose to near 
normal level and protects their sciatic 
nerves against the structural abnormalities 
found in diabetes (Preet et al., 2005).  
According to above studies, there are 
controversial judges about the effects of 
fenugreek on the nervous system. Since 
people of some African and Asian countries 
are using fenugreek because of its anti-
diabetic effects, and taking into account that 
diabetes indigenously has neuro-
pathological side effects, it may worsen 
their peripheral neuropathy if they consume 
neurotoxic supplements. 
In this study electrophysiological and 
behavioral assays were used to investigate 
the effect of hydro-alcoholic extract of fe-
nugreek seed on functional improvement of 
peripheral neuropathy in mice. For this pur-
pose pyridoxine induced neuropathic mice 
were treated with fenugreek seed extract in 
concentrations near to its therapeutic anti-
diabetic doses. 
 
MATERIALS AND METHODS 
Induction of peripheral neuropathy in 
mice  
Totally, 40 male BALB/c mice with the 
average body weight of 40-50 grams, were 
selected and divided into five groups: 1: 
normal (non-neuropathic), 2: control (neu-
ropathic + vehicle treated), 3: neuropathic + 
0.2 mg/kg fenugreek seed extract treated, 4: 
neuropathic + 2mg/kg fenugreek seed ex-
tract treated, and 5: neuropathic + 20 mg/kg 
fenugreek seed extract treated. 
Non-diabetic neuropathy was induced in 
mice, for this purpose they were treated 
with high doses (350 mg/kg, ip) of pyridox-
ine twice a day for eight days (Callizot et 
al., 2001). Before fenugreek therapy, tail 
flick assays were performed to state the in-
cidence of neuropathy in the animals. After 
establishment of neuropathy incidence, fe-
nugreek treatment was initiated and contin-
ued for ten days. For production of injec-
tion solution, 100 gr of seeds were pow-
dered finely, soaked in 80 % ethanol and 
placed in room temperature for five days. 
Then the extract was cleared, filtered, and 
evaporated under the laminar hood; the 
produced dried material was used for treat-
ments. Each group received the specified 
amount of dried material solved in distilled 
water intraperitoneally (i.p). Before injec-
tions, the injection solutions were filtered 
through 0.02 μm filters. The final doses for 
treatments were: 0.2, 2 and 20 mg of dried 
seed extract per kilogram of the body 
weight of animal solved in 250 µl of dis-
tilled water, same amounts of distilled wa-
ter (250 µl) were injected to the animals of 
the control group. 
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Tail flick test 
Tail flick tests were used to obtain the 
spinal tail flick response to the noxious 
thermal stimuli (Rani and Gupta, 2012). In 
this study tail flick tests were performed in 
three sessions: before any procedure, after 
neuropathy induction and finally after fenu-
greek treatment. The tail flick response was 
elicited by using a tail flick apparatus. Each 
mouse was located in strainer and the distal 
half of its tail was situated under the source 
of radiant heat. The time elapsed until the 
animal flicked its tail was determined. Fif-
teen-seconds cut off latency was reserved to 
prevent damage to the tail. 
 
Electrophysiological assay 
After the final tail flick test, animals 
were killed by cervical dislocation, their 
sciatic nerves were removed by surgical 
incision and placed in modified Lock's so-
lution (pH 7.4), which made up of 140 mM 
NaCl, 1.2 mM MgCl2, 5.6 mM KCl, 
2.2 mM CaCl2, 10 mM Tris buffer (tris-
(hydroxymethyl)amino-methane), and 
10 mM glucose. To record electrical events, 
the sciatic nerves were placed in humid 
nerve chamber and for prevention of tissue 
drying drops of Lock's solution were pulled 
on them. CEPTU instrument (Complete 
Electrophysiology Teaching Unit, Wash-
ington Bioscience) was used for electrical 
stimulation of the nerves and their com-
pound action potential acquisition. Isolated 
nerves were stimulated by a defined stimu-
lus (intensity: 1.5 v, delay: 0, width: 
0.05 ms) and their evoked compound action 
potentials were amplified by the gain of 
1000. To monitor the data digitally we used 
a bench top computer and digital oscillo-
scope software. The output wire of amplifi-
er were connected to the microphone wire 
input of the computer, so the computer 
sound card was used as an analog to digital 
board. Digital oscilloscope software 
(Virtins Sound Card Oscilloscope, Multi-
Instrument Software, version 2.1) was used 
to visualize the action potential curve on the 
screen. Images were captured from electri-
cal events of nerves and they were analyzed 
by Image-J software to calculate conduction 
velocity, duration and voltage of action po-
tential in each nerve. 
 
Histochemical staining 
After electrophysiological assays sciatic 
nerves of each animal were placed in 10 % 
paraformaldehyde solution overnight, next 
day they were processed by tissue proces-
sor, after that all of the nerves belonging to 
each group were paraffin embedded sepa-
rately into the different blocks and 5 µm 
thickened transverse sections were harvest-
ed from them with a microtome. Staining 
procedure was continued by deparaffi-
nation, rehydration and incubation of sec-
tions in the 1 % Hematoxilin-Eosin solution 
for eight minutes. Afterward, sections were 
dehydrated and mounted with xylene based 
mounting medium. Three separate sections 
were selected from the beginning, the mid-
dle, and the end of each nerve block, and 
then one image was captured from center of 
the nerve in each section, totally 48 images 
were captured from each group and the 




Data from electrophysiological and his-
tological assays were analyzed with SPSS 
17 software using paired T student test and 
differences were assumed significant when 
P-values were less than 0.05. 
 
RESULTS 
As seen in Figure 1a, the mean nerve 
conduction velocities (NCV) in the control 
(vehicle-treated neuropathic) and 0.2 mg/kg 
treated groups were significantly lower than 
that in the normal group (P<0.011), which 
confirmed the incidence of neuropathy and 
the absence of healing in these groups. 
Fenugreek treatment with 2 and 20 mg/kg 
doses, significantly increased the NCV 
compared to the vehicle treatment (P<0.023 
and P< 0.009, respectively). In comparisons 
between the treated groups with the normal 
group, the NCV was not changed signifi-
cantly when comparing the 20 mg/kg treat-
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ed group with the normal one, which indi-
cated that recovery was occurred in the 
20 mg/kg treated group, while in the other 
treated doses the healing process was not 
complete and the NCV was lower signifi-
cantly compared with the normal group 
(P<0.05).  
Treatment with pyridoxine strongly re-
duced the voltage of action potential (Fig-
ure 1b) in all of the neuropathic groups 
compared with the normal group (P<0.001). 
In comparisons among the fenugreek treat-
ed groups with the non treated group, the 
reduction of the voltage in the 0.2 and 
2 mg/kg treated groups was as similar as 
non-treated neuropathic group, but it was 
significantly greater in the 20 mg/kg treated 
group than that in the other treated animals 
and the control group (P<0.005 and 
P<0.003, respectively). These results indi-
cated that the treatment with 20 mg/kg of 
fenugreek extract was more effective than 
the other doses on restoring the NCV and 
the voltage intensity. Comparisons among 
different groups in the mean duration of 
action potential showed that there were not 
any significant differences (Figure 1c). 
 
 
Figure 1: The effect of fenugreek treatment on electrophysiological parameters of sciatic nerves. a: 
mean conduction velocity, b: mean voltage of compound action potential, c: mean duration of com-
pound action potential (ms). d: mean delay in tail flick test. Groups are as same as those represented 
in a. e: example graphs of nerve compound action potentials recorded from the different groups, at 
each graph the first sharp wave is the stimulus and the second one is the response of the nerve. Error 
bars representing the standard error of mean. 
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Data of the tail flick tests (Figure 1d) 
represented that there were significant in-
creases in the mean latencies in the control 
and the 0.2 mg/kg treated groups compared 
with the normal group (P<0.03 and 
p<0.016, respectively). Differences in the 
mean latency of the tail flick were not sig-
nificant when comparing the 2 mg/kg and 
the 20 mg/kg fenugreek treated animals 
with the normal group (P<0.09 and 
P<0.061, respectively). Otherwise, in com-
parisons among the treated groups with the 
control animals, despite, the mean latency 
was lower in the 20 mg/kg treated group, 
but the differences were not statistically 
significant as well as the other treated 
groups. Taking all together, results of tail 
flick tests showed controversy; on the one 
hand, there was no significant difference 
when comparing the normal and control 
groups with the 20 mg/kg treated group, 
while on the other hand, the difference be-
tween the control group and the normal 
group was significant. This controversy 
could be as a result of the diversities in the 
pain threshold among animals, which is al-
ways a distorting parameter in this kind of 
behavioral assays. 
As it was predicted, there were signifi-
cant differences in the mean number of ax-
ons existed in the nerves when comparing 
the normal group with the other groups 
(P<0.001), which states that there was a 
significant loss in the number of nerve fi-
bers in all of the neuropathic groups. In 
comparisons among the neuropathic sub-
jects, the highest number of nerve fibers 
were counted in the 20 mg/kg treated ani-
mals as compared with the other neuro-
pathic groups (p<0.01), which confirmed 




Damage to the cell membrane due to the 
high exposure to free radicals, as it happens 
in the diabetes, is one of the major reasons 
for peripheral neuropathy. Therefore diabet-
ic patients beside difficulties in the control 
of their blood glucose are always under the 
risk of neuropathy incidence. There are 
several herbal drugs with known anti-
diabetic effects, but there is not enough data 
about their safety for the nervous system. 
Usage of these kinds of herbals could help 
to decrease the blood glucose but may af-
fect the neuropathy and worsen it. Among 
these drugs fenugreek and its derivatives 
such as trigonelline like to be neuroprotec-
tive, but there are some reports about their 
adverse effects on the nervous system dur-
ing developmental growth (Khalki et al., 
2010, 2012).  
 
Figure 2: Cross sections of mice sciatic nerves stained with H&E (with 40X magnification) from differ-
ent groups, a: Normal, b: Neuropathic, c: Neuropathic + 0.2 mg/kg fenugreek, d: Neuropathic + 
2 mg/kg fenugreek, e: Neuropathic + 20 mg/kg fenugreek. f: The mean number of nerve fibers count-
ed in the nerve sections of the different groups. Error bars in f representing the standard error of mean 
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Results of the present study indicated 
that in the low to moderate doses fenugreek 
is safe for the nervous system and could 
help to improve the function of the nerve 
fibers. Electrophysiological data indicated 
that, NCV and voltage of action potential 
were improved in the 20 mg/kg fenugreek 
treated neuropathic mice. However, behav-
ioral data was not completely in accordance 
with the electrophysiological assays, which 
could be due to differences among animals 
in the pain threshold, and the differences in 
compatibility with the conditions of the test, 
which could strongly affect the results of 
behavioral assays.  
Results of histological staining were in 
accordance with the results of electrical as-
says since the higher rate of axon recovery 
was seen in the 20 mg/kg treated group. 
Considering the overall results of this study, 
fenugreek seed extract remedy exerts some 
improving effects on the function of neuro-
pathic nerves. Our study confirmed the re-
sults of previous studies that treatment with 
Trigonella foenum graecum seed powder 
restored the histopathological alterations in 
the sciatic nerves and ocular tissues of dia-
betic rats (Preet et al., 2005, 2006).  
The healing effects of fenugreek seed 
extract could be assigned to its nutraceuti-
cals such as trigonelline and 4-hydroxy iso-
leuscine (Moorthy et al., 2010; Morani et 
al., 2012; Zhao et al., 2002; Zhou et al., 
2012). Trigonelline exists abundantly in 
fenugreek seed, and previous reports con-
firmed that it exerts a healing effect on the 
pyridoxine induced auditory neuropathy in 
mice (Hong et al., 2009). Furthermore, it 
has been reported that trigonelline regener-
ates neurite outgrowth and reconstructs 
synapses in the neuroblastoma cell lines 
(Tohda et al., 1999, 2005). Since trigonel-
line is a nicotinic acid derivative and nico-
tinic acid elevates the mRNA expression of 
nerve growth factor (NGF) and brain-
derived neurotrophic factor (BDNF), if 
trigonelline exerts similar effects, this could 
be considered as a possible mechanism in-
volved in the neuroprotective effects of 
fenugreek seed extract (Brailoiu et al., 
2005; French et al., 1999; Qiao et al., 2003; 
Rosato-Siri et al., 2006; Serres and Carney, 
2006). Based on the reported data, the insu-
linotropic effect of fenugreek seeds could 
restore the structural alterations of sciatic 
nerves in alloxan induced diabetic rats 
(Preet et al., 2005). This insulinotropic 
property was attributed to the presence of 
high concentration of 4-hydroxyisoleucine 
in its extract, which directly stimulates in-
sulin secretion from pancreatic beta cells 
(Broca et al.,1999, 2000, 2004; Gupta et al., 
2001). Since there are some developmental 
similarities between neurons and beta cells, 
so 4-hydroxyisoleucine could exert similar 
effect on the neurons (Furuzawa et al., 
1996). On the other hand, as well as stimu-
lating insulin secretion, 4-hydroxyiso-
leucine decreases the insulin resistance in 
peripheral tissues and liver by stimulating 
insulin receptor substrate-associated phos-
phatidylinositol (PI) 3-kinase activity 
(Jaiswal et al., 2012). Furthermore, NGF 
and BDNF receptors need PI3 kinase path-
way to exert their anti-apoptotic and nerve 
growth stimulating effects (Bui et al., 2002; 
Culmsee et al., 2002; Nguyen et al., 2010). 
Overall, trigonelline increases NGF and 
BDNF, while 4-hydroxyisoleucine increas-
es insulin and activates insulin dependent 
PI3-kinase pathway which is necessary for 
neuroprotective function of NGF and 
BDNF, so these interactions between 
trigonelline, nerve growth factor, 4-
hydroxyisoleucine and insulin could bring 
reasonable explanation for its neuroprotec-
tive effects.  
In conclusion, our findings represented 
that fenugreek seed extract is neuro-
regenerative and its consumption as an anti-
diabetic remedy, beside elevating the insu-
lin secretion and lowering the blood glu-
cose, could be beneficial for the control of 
peripheral neuropathy. 
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